Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation

We aimed to identify whether the use of autologous hematopoietic cell transplantation (HCT) impacts outcomes for multiple myeloma patients with gains of chromosome 1q (+1q). We retrospectively identified 95 patients, 21% having +1q. For patients with +1q, the overall response rate to induction was 8...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Leuk Lymphoma
Autors principals: Shah, Gunjan L., Landau, Heather, Londono, Dory, Devlin, Sean M., Kosuri, Satyajit, Lesokhin, Alexander M., Lendvai, Nikoletta, Hassoun, Hani, Chung, David J., Koehne, Guenther, Jhanwar, Suresh C., Landgren, Ola, Levine, Ross, Giralt, Sergio A.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5554510/
https://ncbi.nlm.nih.gov/pubmed/28078910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2016.1260126
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars